Now Also Available in a 1 g tube!
Proof positive for more eyes
Profound activity against common gram-positive pathogens -- Streptococci, Staphylococci1, and MRSA2,3--with a sensitivity profile that's remained virtually unchanged over time4
References: 1. Bacitracin Ophthalmic Ointment [Package Insert]. Locust Valley, NY, Fera Pharmaceuticals, LLC, 2009. 2. Kowalski RP, Karenchak LM, Romanowski EG. Infectious disease: changing antibiotic susceptibility. Ophthalmol Clin N Am 2003;16:1-9. 3. Freidlin J, Acharya N, Lietman TM, Cevallos V, Whitcher JP, Margolis TP. Spectrum of eye disease caused by methicillin-resistant Staphylococcus aureus. Am J Ophthalmol 2007;144:313-315. 4. Recchia FM, Busbee BG, Pearlman RB, Carvalho-Recchia CA, Ho AC. Changing trends in the microbiologic aspects of postcataract endophthalmitis. Arch Ophthalmol 2005;123:341-346.
Bacitracin Ophthalmic Ointment is indicated for the treatment of superficial ocular infections involving the conjunctiva and/or cornea caused by Bacitracin susceptible organisms.
Important Safety Information
Bacitracin ophthalmic ointment should not be used in deep-seated ocular infections or in those that are likely to become systemic.
This product should not be used in patients with a history of hypersensitivity to Bacitracin.